Science Explorer Interactive view Map
Company · Boulogne-Billancourt · France

Gilead Sciences (France)

gilead.com/about/worldwide-operations/europe/franceROR OpenAlex
Research works
60
▲ 60% vs 2013–17
Citations
840
14.0 per fractional work
Top-10% rate
7.7%
record average 16.5%
Open access
36%
world 28%

Not ranked overall: Gilead Sciences (France) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.04× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.77× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 6.40× its world share, 1 worksImmunology and Micro…Computer Science: 0.35× its world share, 0 worksComputer ScienceEngineering: 0.06× its world share, 0 worksEngineeringEnvironmental Science: 0.12× its world share, 0 worksEnvironmental ScienceMathematics: 2.00× its world share, 0 worksMathematicsHealth Professions: 0.12× its world share, 0 worksHealth ProfessionsMedicine: 3.99× its world share, 8 worksMedicineArts and Humanities: 0.23× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.05× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.71× its world share, 0 worksEconomics, Econometr…Psychology: 0.06× its world share, 0 worksPsychologySocial Sciences: 0.26× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.4×. Every wedge is a field page.

Which keywords describe research at Gilead Sciences (France)?

By fractional works in all years, weighted toward what it does more of than the world: Treatment, Immune Response, Hypertension, Global Burden, Epidemiology, Liver Disease, Antiviral Therapy and Immunotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology7▲ 2.8×31 topics
  2. Treatment6▲ 8.3×17 topics
  3. Immune Response5▲ 14×9 topics
  4. Hypertension4▲ 20×6 topics
  5. Cardiovascular Disease4▲ 6.1×11 topics
  6. Global Burden4▲ 13×8 topics
  7. Antiviral Therapy4▲ 43×3 topics
  8. Liver Disease4▲ 48×3 topics
  9. Immunotherapy4▲ 9.8×11 topics
  10. Cardiovascular Events4▲ 38×4 topics
  11. Antiretroviral Therapy4▲ 26×5 topics
  12. Lymphoma3▲ 38×3 topics
  13. Diagnosis3▲ 4.9×11 topics
  14. Hepatitis C Virus3▲ 88×1 topic
  15. Ribavirin3▲ 88×1 topic
  16. Clinical Guidelines3▲ 14×4 topics
  17. Risk Factors3▲ 4.3×5 topics
  18. Drug Resistance2▲ 13×5 topics
  19. Blood Pressure2▲ 58×2 topics
  20. Diabetes Mellitus2▲ 17×2 topics
  21. Hepatocellular Carcinoma2▲ 18×3 topics
  22. Prognostic Factors2▲ 8.7×8 topics
  23. Antihypertensive Drugs2▲ 69×1 topic
  24. Cancer Immunotherapy2▲ 27×2 topics
  25. Heart Failure2▲ 8.3×5 topics
  26. Renal Denervation2▲ 69×1 topic
  27. Innovation2▲ 4.1×3 topics
  28. Metabolic Syndrome2▲ 4.3×4 topics
  29. Tumor Regression2▲ 42×2 topics
  30. CAR T Cells2▲ 81×1 topic
  31. Chimeric Antigen Receptor2▲ 81×1 topic
  32. Rituximab2▲ 21×2 topics
  33. Classification2▲ 8.7×2 topics
  34. HIV Infection2▲ 23×2 topics
  35. PET Imaging2▲ 13×4 topics
  36. Hepatotoxicity2▲ 34×2 topics
  37. Radiosurgery2▲ 27×4 topics
  38. Integrase Inhibitors1▲ 56×1 topic
  39. Nucleoside Analogues1▲ 56×1 topic
  40. Neurological Complications1▲ 30×2 topics

Which research topics does Gilead Sciences (France) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Biotechnology and Related Fields, Electrolyte and hormonal disorders and Lymphoma Diagnosis and Treatment.

CAR-T cell therapy resea…1CAR-T cell therapy research: 1 fractional worksBiotechnology and Related Fields: 1 fractional worksElectrolyte and hormonal disorders: 1 fractional worksLymphoma Diagnosis and Treatment: 1 fractional worksHepatitis C virus research: 0 fractional worksHIV/AIDS drug developmen…0HIV/AIDS drug development and treatment: 0 fractional worksBiosimilars and Bioanalytical Methods: 0 fractional worksChronic Lymphocytic Leukemia Research: 0 fractional worksBreast Cancer Treatment Studies: 0 fractional worksAdvanced Breast Cancer Therapies: 0 fractional works
OncologyPublic Health, Environmental and Occupational HealthPulmonary and Respiratory MedicinePathology and Forensic Medicine5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 1 works
  2. 2 Biotechnology and Related Fields Public Health, Environmental and Occupational Health 1 works
  3. 3 Electrolyte and hormonal disorders Pulmonary and Respiratory Medicine 1 works
  4. 4 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
  5. 5 Hepatitis C virus research Hepatology 0 works
  6. 6 HIV/AIDS drug development and treatment Infectious Diseases 0 works
  7. 7 Biosimilars and Bioanalytical Methods Immunology 0 works
  8. 8 Chronic Lymphocytic Leukemia Research Genetics 0 works
  9. 9 Breast Cancer Treatment Studies Cancer Research 0 works
  10. 10 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available35.8%not open64.2%

World: 28% of research is openly available.

with international co-authors65.9%domestic only34.1%

World: 19% is written across borders.

How has Gilead Sciences (France)'s research output changed?

Output in 2018–2022 was 60% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Boulogne-Billancourt

All research institutions in Boulogne-Billancourt

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.